Steve Lee

Colleges, School and Institutes

Willingness to take PhD students

Yes

PhD projects

Dr Lee is interested in supervising doctoral research in the following areas:

• Immune responses to viruses and human cancer
• Immune-based therapies for human cancer

View graph of relations

Most downloaded publications

The human lymph node microenvironment unilaterally regulates T cell activation and differentiation
Konstantin Knoblich, Sara Cruz Migoni, Susan Siew, Hannah Jeffery, Katerina Vrzalikova, Paul Murray, Francesca Barone, Philip Newsome, Gideon Hirschfield, Ye Htun Oo, Steve Lee & Anne Fletcher, 4 Sep 2018, In : PLoS Biology.

Research output: Contribution to journal › Article › peer-review

755 downloads
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
Heather Long, Nancy Gudgeon, Jill Brooks, Steve Lee, Alan Rickinson & Graham Taylor, 15 Apr 2005, In : Journal of virology. 79, p. 4896-4907 12 p.

Research output: Contribution to journal › Article › peer-review

242 downloads
Tspan18 is a novel regulator of the Ca2+ channel Orai1 and von Willebrand factor release in endothelial cells
Peter Noy, Elizabeth Haining, Jasmeet Reyat, Neale Harrison, Victoria Heath, Joseph Robinson, Paul Harrison, Steve Lee & 7 others, , Neena Kalia, Ed Rainger, Alexander Brill, Steve Watson & Michael Tomlinson, Sep 2019, In : Haematologica. 104, 9, p. 1892-1905 34 p.

Research output: Contribution to journal › Article › peer-review

118 downloads
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
Frederick Chen, Heather Long, Steve Lee & Gavin Bendle, 13 Jul 2018, In : Journal for ImmunoTherapy of Cancer. 6, 14 p., 70.

Research output: Contribution to journal › Article › peer-review

114 downloads
Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma: TCR gene transfer to target NPC
Yong Zheng, Gregory Parsonage, Peter Searle & Steve Lee, 24 Feb 2015, In : Cancer immunology research.

Research output: Contribution to journal › Article › peer-review

112 downloads

Recent publications

An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
Joseph Robinson, Zsuzsanna Nagy, Roy Bicknell & Steve Lee, 21 Oct 2020, In : Journal of Pathology: Clinical Research. 6, 4, p. 308-319 12 p.

Research output: Contribution to journal › Article › peer-review

CAR T-cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
Joseph Robinson, Neeraj Jumbu, Jonas Bystrom, Zsuzsanna Nagy, Roy Bicknell & Steve Lee, 2 Oct 2020, In : JCI Insight. 5, 19, 19 p., e138808.

Research output: Contribution to journal › Article › peer-review

Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity
Sarah Booth, Vanessa Tubb, Andris Jankevics, Andrew Southam, Steve Lee, Warwick Dunn & Carmela De Santo, 23 Jun 2020, In : Blood.

Research output: Contribution to journal › Article › peer-review

View all (37)